BSX vs SW · P/E 20, rev $10.65B vs P/E 59, rev $31.18B
Boston Scientific Corp (BSX) versus Smurfit WestRock plc (SW) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Smurfit WestRock plc (SW) is a packaging & containers company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SW revenue for 2025-12-31 was $31.18B. Net income was $699.0M. Revenue was up 47.7% from 2024-12-31 to 2025-12-31. SW currently screens at market cap $22.09B and trailing P/E 58.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SW currently screens at market cap $22.09B and trailing P/E 58.5.
Not investment advice. Open the BSX and SW stock pages for the full models.
Not investment advice.